Europe’s first psychedelic drug trial firm to open in London
May 16 2022 – Team MindFuel
British start up Clerkenwell Health have opened Europe's first commercial facility for psychedelic drug trials with the goal of making the United Kingdom a global leader in psychedelic research and innovation.
They aim to begin clinical trials at their central London facility in August, initially focusing on psilocybin for anxiety associated with diagnoses of terminal illness.
They aim to begin clinical trials at their central London facility in August, initially focusing on psilocybin for anxiety associated with diagnoses of terminal illness.
Here at MindFuel we wish them the best of luck. You can read the full article at the Guardian link below.
Source: The Guardian.
*Special thanks to Alan Rockefeller for the beautiful pic of (Psilocybe aztecorum).
0 comments